Advertisement
Screener

OCULAR THERAPEUTIX, INC (OCUL) Other

OCULAR THERAPEUTIX, INC Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-02-05: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · OCUL · Nasdaq Global Market.
  • 2025-03-03: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · OCUL · Nasdaq Global Market.
  • 2024-11-14: Form 10-Q; Item Smaller reporting company; As filed Yes.
  • 2024-08-07: Form 10-Q; Item Smaller reporting company; As filed Yes.
FiledFormItemAs filed
2026-02-0510-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUL · Nasdaq Global Market
2025-03-0310-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUL · Nasdaq Global Market
2024-11-1410-QSmaller reporting companyYes
2024-08-0710-QSmaller reporting companyYes
2024-05-0710-QSmaller reporting companyYes
2024-03-1110-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUL · Nasdaq Global Market
2024-03-1110-KSmaller reporting companyYes
2023-11-0710-QSmaller reporting companyYes
2023-08-0710-QSmaller reporting companyYes
2023-05-0810-QSmaller reporting companyYes
2023-03-0610-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUL · Nasdaq Global Market
2023-03-0610-KSmaller reporting companyYes
2023-03-0610-KWell-known seasoned issuerNo
2022-02-2810-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUL · Nasdaq Global Market
2022-02-2810-KSmaller reporting companyYes
2022-02-2810-KWell-known seasoned issuerNo
2021-11-0810-QSmaller reporting companyYes
2021-08-0910-QSmaller reporting companyYes
2021-05-0510-QSmaller reporting companyYes
2021-03-1110-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUL · Nasdaq Global Market
2021-03-1110-KSmaller reporting companyYes
2020-11-0510-QSmaller reporting companyYes
2020-08-0710-QSmaller reporting companyYes
2020-05-0810-QSmaller reporting companyYes
2020-03-1210-KSmaller reporting companyYes
2020-03-1210-KWell-known seasoned issuerNo
2019-11-1210-QSmaller reporting companyYes
2019-11-1210-QEmerging growth companyYes
2019-08-0710-QSmaller reporting companyYes
2019-08-0710-QEmerging growth companyYes
2019-05-1010-QSmaller reporting companyYes
2019-05-1010-QEmerging growth companyYes
2019-03-0710-KWell-known seasoned issuerNo
2018-03-0810-KWell-known seasoned issuerNo
2017-03-1010-KWell-known seasoned issuerNo
2016-03-1010-KWell-known seasoned issuerNo
2015-03-2010-KWell-known seasoned issuerNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Zai Lab Ltd (ZLAB)$2.241B-113.34
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05